Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,197.70
+34.40 (1.59%)
Mar 10, 2026, 9:40 AM IST
Mankind Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Market Capitalization | 893,021 | 1,000,400 | 921,654 | - | - | - | Upgrade
|
| Market Cap Growth | -9.60% | 8.54% | - | - | - | - | Upgrade
|
| Enterprise Value | 944,149 | 960,198 | 902,241 | - | - | - | Upgrade
|
| Last Close Price | 2163.30 | 2423.79 | 2299.84 | - | - | - | Upgrade
|
| PE Ratio | 50.07 | 50.25 | 48.18 | - | - | - | Upgrade
|
| Forward PE | 38.33 | 45.13 | 43.88 | - | - | - | Upgrade
|
| PS Ratio | 6.42 | 8.20 | 8.98 | - | - | - | Upgrade
|
| PB Ratio | 5.75 | 6.87 | 9.63 | - | - | - | Upgrade
|
| P/TBV Ratio | - | - | 12.00 | - | - | - | Upgrade
|
| P/FCF Ratio | - | 51.24 | 50.17 | - | - | - | Upgrade
|
| P/OCF Ratio | - | 41.45 | 42.82 | - | - | - | Upgrade
|
| PEG Ratio | 2.31 | 2.64 | 1.91 | - | - | - | Upgrade
|
| EV/Sales Ratio | 6.79 | 7.87 | 8.79 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 29.00 | 32.12 | 35.87 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 37.79 | 39.89 | 41.96 | - | - | - | Upgrade
|
| EV/FCF Ratio | - | 49.18 | 49.11 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.54 | 0.58 | 0.02 | 0.02 | 0.14 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 2.58 | 2.84 | 0.08 | 0.09 | 0.44 | 0.16 | Upgrade
|
| Debt / FCF Ratio | - | 4.36 | 0.11 | 0.17 | 1.94 | 0.34 | Upgrade
|
| Net Debt / Equity Ratio | 0.31 | 0.41 | -0.34 | -0.18 | -0.06 | -0.35 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.51 | 2.00 | -1.29 | -0.71 | -0.20 | -1.01 | Upgrade
|
| Net Debt / FCF Ratio | - | 3.07 | -1.77 | -1.32 | -0.87 | -2.07 | Upgrade
|
| Asset Turnover | - | 0.62 | 0.95 | 0.93 | 1.00 | 1.09 | Upgrade
|
| Inventory Turnover | - | 2.01 | 2.17 | 1.84 | 1.69 | 1.77 | Upgrade
|
| Quick Ratio | - | 0.73 | 2.05 | 1.14 | 0.65 | 1.78 | Upgrade
|
| Current Ratio | - | 1.23 | 3.10 | 2.32 | 1.68 | 2.89 | Upgrade
|
| Return on Equity (ROE) | - | 16.62% | 22.57% | 18.79% | 25.99% | 30.30% | Upgrade
|
| Return on Assets (ROA) | - | 7.58% | 12.40% | 10.53% | 14.76% | 17.37% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.07% | 14.28% | 27.63% | 20.42% | 29.77% | 41.50% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 10.90% | 21.80% | 20.20% | 28.10% | 31.70% | Upgrade
|
| Earnings Yield | 1.99% | 1.99% | 2.08% | - | - | - | Upgrade
|
| FCF Yield | - | 1.95% | 1.99% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -2.76% | -0.88% | -0.14% | -0.00% | - | - | Upgrade
|
| Total Shareholder Return | -2.66% | -0.88% | -0.14% | -0.00% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.